EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Statistical Analysis Plan for a Randomized Controlled Trial of Intensive Blood Pressure Control on Cardiovascular Risk Reduction in Patients with Atrial Fibrillation

Xiaolei Lin, Chao Jiang, Zhiyan Wang, Hisatomi Arima, Xia Wang, Laurent Billot, Bruce Neal, Anthony Rodgers, Graham S Hillis, Anushka Patel, Qiang Li, Jianzeng Dong und 3 weitere

Cerebrovascular Diseases · 2025

DOI: 10.1159/000548288 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cerebrovascular Diseases, 2025. Verfasst von Xiaolei Lin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Data Science, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Antihypertensive Agents, Hypertension, Blood Pressure. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction: Elevated blood pressure (BP) is a key modifiable risk factor for cardiovascular (CV) complications in patients with atrial fibrillation (AF). While current guidelines recommend modest BP targets, the optimal target in AF patients remains uncertain. The Cardiovascular Risk Reduction in Atrial Fibrillation Trial (CRAFT) is a multicenter, prospective, randomized, open-label, blinded endpoint trial that evaluates whether intensive home systolic BP control (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAntihypertensive AgentsHypertensionBlood PressureResearch DesignHumansProspective StudiesTreatment OutcomeStrokeRisk FactorsTime FactorsHeart Disease Risk FactorsRisk Reduction BehaviorRisk AssessmentData Interpretation, StatisticalFemaleCardiovascular Diseases

Stichwörter der Autor:innen

Atrial fibrillationBlood pressureClinical trialHypertensionStatistical analysis plan

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Data Science, Fudan University, Shanghai, China.
  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
  • Heart Health Research Center, Beijing, China.
  • Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
  • The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Zitieren

APA

Lin, X., Jiang, C., Wang, Z., Arima, H., Wang, X., Billot, L., Neal, B., Rodgers, A., Hillis, G. S., Patel, A., Li, Q., Dong, J., Du, X., Anderson, C. S., & Ma, C. (2025). Statistical Analysis Plan for a Randomized Controlled Trial of Intensive Blood Pressure Control on Cardiovascular Risk Reduction in Patients with Atrial Fibrillation. Cerebrovascular Diseases. https://doi.org/10.1159/000548288

Vancouver

Lin X, Jiang C, Wang Z, Arima H, Wang X, Billot L, et al. Statistical Analysis Plan for a Randomized Controlled Trial of Intensive Blood Pressure Control on Cardiovascular Risk Reduction in Patients with Atrial Fibrillation. Cerebrovascular Diseases. 2025. doi:10.1159/000548288

BibTeX
@article{Lin2025,
  author = {Lin, Xiaolei and Jiang, Chao and Wang, Zhiyan and Arima, Hisatomi and Wang, Xia and Billot, Laurent and Neal, Bruce and Rodgers, Anthony and Hillis, Graham S and Patel, Anushka and Li, Qiang and Dong, Jianzeng and Du, Xin and Anderson, Craig S and Ma, Changsheng},
  title = {Statistical Analysis Plan for a Randomized Controlled Trial of Intensive Blood Pressure Control on Cardiovascular Risk Reduction in Patients with Atrial Fibrillation},
  journal = {Cerebrovascular Diseases},
  year = {2025},
  doi = {10.1159/000548288}
}
Kostenlos starten →